Astellas Pharma Inc. ADR (ALPMY)
Market Closed
23 Feb, 20:00
OTC PINK OTC PINK Primary $
15. 96
+0.03
+0.19%
$
17.76B Market Cap
- P/E Ratio
0.88% Div Yield
97,400 Volume
- Eps
$ 15.93
Previous Close Day Range
15.91 16.1
Year Range
8.37 16.95
Want to track ALPMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ALPMY earnings report is expected in 58 days (23 Apr 2026)
Japan's Astellas says employee indicted by China's prosecutors
Chinese authorities have indicted a Japanese employee of Astellas Pharma Inc , who had been detained in China since March 2023 on suspicion of espionage, the Japanese pharmaceutical company said on Wednesday.
Reuters | 1 year ago
UK regulator approves Astellas' gastric cancer drug
Britain's health regulator said on Wednesday it has approved Astellas Pharma's drug to treat a type of gastric cancer.
Reuters | 1 year ago
